Details for Patent: 6,902,744

✉ Email this page to a colleague

Summary for Patent: 6,902,744

Title:	Exendin agonist formulations and methods of administration thereof
Abstract:	Novel exendin and exendin agonist compound formulations and dosages and methods of administration thereof are provided. These compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.
Inventor(s):	Kolterman; Orville G. (Poway, CA), Young; Andrew A. (La Jolla, CA)
Assignee:	Amylin Pharmaceuticals, Inc. (San Diego, CA)
Application Number:	09/889,330
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,902,744
Patent Claim Types: see list of patent claims	Formulation; Compound; Dosage form;

Drugs Protected by US Patent 6,902,744

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,902,744

PCT Information
PCT Filed	January 14, 2000	PCT Application Number:	PCT/US00/00902
PCT Publication Date:	July 20, 2000	PCT Publication Number:	WO00/41546

International Family Members for US Patent 6,902,744

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1140145	⤷ Sign Up	CA 2007 00033	Denmark	⤷ Sign Up
European Patent Office	1140145	⤷ Sign Up	91343	Luxembourg	⤷ Sign Up
European Patent Office	1140145	⤷ Sign Up	SZ 30/2007	Austria	⤷ Sign Up
European Patent Office	1140145	⤷ Sign Up	30/2007	Austria	⤷ Sign Up
Austria	275967	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.